Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,184 | -57,762 | -50,333 | -27,940 | -41,852 |
| Depreciation Amortization | -7,475 | -103 | 1,526 | 681 | 108 |
| Income taxes - deferred | 155 | 46 | -214 | 0 | 0 |
| Accounts receivable | 225 | 24,602 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 6,519 | 5,557 | 5,970 | -491 | 816 |
| Other Working Capital | -49,233 | 4,931 | 28,099 | 51,896 | 3,396 |
| Other Operating Activity | 2,981 | -21,025 | -296 | 5,938 | 2,186 |
| Operating Cash Flow | $-79,012 | $-43,754 | $-15,248 | $30,084 | $-35,346 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -55,072 | -112,936 | -52,362 | -72,017 | 17,584 |
| PPE Investments | -487 | -412 | -118 | -802 | -821 |
| Investing Cash Flow | $-55,559 | $-113,348 | $-52,480 | $-72,819 | $16,763 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,000 | 1,977 |
| Debt Repayment | -3,425 | -4,800 | -2,400 | N/A | -1,333 |
| Common Stock Issued | 166,696 | 107,489 | 103,164 | 56,381 | 23,611 |
| Other Financing Activity | 1,851 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $165,122 | $102,689 | $100,764 | $61,381 | $24,255 |
| Exchange Rate Effect | 8 | -118 | -88 | 58 | -6 |
| Beginning Cash Position | 13,630 | 68,161 | 35,213 | 16,509 | 10,843 |
| End Cash Position | 44,189 | 13,630 | 68,161 | 35,213 | 16,509 |
| Net Cash Flow | $30,559 | $-54,531 | $32,948 | $18,704 | $5,666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,012 | -43,754 | -15,248 | 30,084 | -35,346 |
| Capital Expenditure | -487 | -412 | -118 | -802 | -821 |
| Free Cash Flow | -79,499 | -44,166 | -15,366 | 29,282 | -36,167 |